Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Nilsson

Showing results (211-220 of 288) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2003
Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401Yvonne Brandberg, Helena Michelson, Bo Nilsson, et al.
Cancer Immunology, Immunotherapy : CII|May 20, 2008
Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal studyFariba Mozaffari, Christina Lindemalm, Aniruddha Choudhury, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 15, 2007
Immune response, depression and fatigue in relation to support intervention in mammary cancer patientsChristina Lindemalm, Fariba Mozaffari, Aniruddha Choudhury, et al.
Biomaterials|January 28, 2014
Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesiclesYvonne Klapper, Osama A Hamad, Yuji Teramura, et al.
Transplantation|February 4, 2011
The instant blood-mediated inflammatory reaction characterized in hepatocyte transplantationElisabet K Gustafson, Graciela Elgue, Robin D Hughes, et al.
ACS Applied Materials & Interfaces|May 8, 2020
Identification of Metal-Binding Peptides and Their Conjugation onto Nanoparticles of Superparamagnetic Iron Oxides and LiposomesTomonobu Kodama, Akifumi Yoshihara, Isha Goel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2015
Rare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activityGeorgia Sfyroera, Daniel Ricklin, Edimara S Reis, et al.
Nature|September 24, 2005
Structures of complement component C3 provide insights into the function and evolution of immunityBert J C Janssen, Eric G Huizinga, Hans C A Raaijmakers, et al.
Thrombosis and Haemostasis|January 7, 2021
The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid AntibodiesGiorgia Grosso, Kerstin Sandholm, Aleksandra Antovic, et al.
Frontiers in Immunology|March 11, 2021
The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin SystemMiklós Lipcsey, Barbro Persson, Oskar Eriksson, et al.
Pageof 29

Showing results (211-220 of 288) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2003
Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401Yvonne Brandberg, Helena Michelson, Bo Nilsson, et al.
Cancer Immunology, Immunotherapy : CII|May 20, 2008
Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal studyFariba Mozaffari, Christina Lindemalm, Aniruddha Choudhury, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 15, 2007
Immune response, depression and fatigue in relation to support intervention in mammary cancer patientsChristina Lindemalm, Fariba Mozaffari, Aniruddha Choudhury, et al.
Biomaterials|January 28, 2014
Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesiclesYvonne Klapper, Osama A Hamad, Yuji Teramura, et al.
Transplantation|February 4, 2011
The instant blood-mediated inflammatory reaction characterized in hepatocyte transplantationElisabet K Gustafson, Graciela Elgue, Robin D Hughes, et al.
ACS Applied Materials & Interfaces|May 8, 2020
Identification of Metal-Binding Peptides and Their Conjugation onto Nanoparticles of Superparamagnetic Iron Oxides and LiposomesTomonobu Kodama, Akifumi Yoshihara, Isha Goel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2015
Rare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activityGeorgia Sfyroera, Daniel Ricklin, Edimara S Reis, et al.
Nature|September 24, 2005
Structures of complement component C3 provide insights into the function and evolution of immunityBert J C Janssen, Eric G Huizinga, Hans C A Raaijmakers, et al.
Thrombosis and Haemostasis|January 7, 2021
The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid AntibodiesGiorgia Grosso, Kerstin Sandholm, Aleksandra Antovic, et al.
Frontiers in Immunology|March 11, 2021
The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin SystemMiklós Lipcsey, Barbro Persson, Oskar Eriksson, et al.
Pageof 29